Similarly, this kinase is widely expressed in pediatric sarcomas, such as EWS, and its pharmacological inhibition (PHA-767491) enhanced the mithramycin-mediated suppression of the EWS-FLI1 transcriptional program, leading to a shift in the IC50 and striking regressions of mouse xenografts. Here, EWSR1 is linked to sarcoma.